Mocravimod dihydrochloride

N/A

Report date: 2024/03/28 17:42:49
NME

Base Information

Drug NameMocravimod dihydrochloride
Drug Alias NameKRP-203KNF-299KRP203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor modulators
TargetsSphingosine 1-phosphate receptor
Therapy Area/IndicationsLupus Erythematosus, CutaneousColitis, UlcerativeHematologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[18] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPriothera LtdPriothera SAS
Inactive CompaniesNovartis Pharma Ag
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsLupus Erythematosus, CutaneousColitis, UlcerativeHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A